Search

Your search keyword '"Stein, Lee"' showing total 25 results
Start Over Author "Stein, Lee"
25 results on '"Stein, Lee"'

5. Modeling passive millimeter wave imaging sensor performance for discriminating small watercraft

Author

Boettcher, Evelyn J., Krapels, Keith, Driggers, Ron, Garcia, Jose, Schuetz, Christopher, Samluk, Jesse, Stein, Lee, Kiser, William, Visnansky, Andrew, Grata, Jeremy, Wikner, David, and Harris, Russ

Subjects
Imaging systems -- Equipment and supplies, Imaging systems -- Technology application, Millimeter waves -- Research, Sensors -- Technology application, Technology application, Astronomy, Physics
Abstract

Passive millimeter wave (pmmW) imagers are quickly becoming practical sensor candidates for military and nonmilitary tasks. Our focus was to adapt the Night Vision [U.S. Army Research Development and Engineering Command, Communications and Electronics Research Development and Engineering Center, Night Vision and Electronics Sensors Directorate (NVESD)] passive thermal infrared imager performance models and apply them to pmmW imaging systems for prediction of field performance for the task of small watercraft and boat identification. The Night Vision Lab's infrared sensor model has been evolving since the 1950s, with the most current model being NVThermIP [Night Vision Thermal and Image Processing (NVThermIP) Model Users Manual, Rev. 9 (U.S. Army RDECON, CERDEC, NVESD, 2006)]. It has wide recognition as an engineering tool for sensor evaluation. This effort included collecting pmmW signatures for a representative set of targets, conducting an observer perception experiment, and deriving the task difficulty criteria that can be used in NVThermIP for identification of boats. The task difficulty criteria are used by designers and managers to create systems capable of meeting specific performance criteria in the field. [c] 2010 Optical Society of America OCIS codes: 040.6808, 040.2235, 110.6820, 110.6795.

Published
2010

7. Perils and pitfalls of practical cybercommerce

Author

Borenstein, Nathaniel S., Ferguson, John, Hall, Jerry, Lowery, Carlyn, Mintz, Rich, Morris, Joanie, New, Darren, Parenti, Beverly, Rose, Marshall, Stefferud, Einar, Stein, Lee, Storm, Carey, Vielmetti, Ed, Weiser, Marc, and Wolff, Pierre-R.

Subjects
Electronic commerce, Financial services industry, Internet, First Virtual Holdings Inc. -- Services, Electronic commerce -- Innovations -- Services, Financial services industry -- Innovations -- Services, Internet -- Services
Abstract

The first year in the life of First Virtual Holdings - a pioneering Internet-based service company - was conducted with little fanfare, yet filled with memorable challenges and experiences. Here, […]

Published
1996

8. Contributors

Author

Abts, David, Albertz, Megan L., Ansari, Sama, Arboleda, Nicole, Arora, Sona S., Bengson, Charles J., Benish, Bethany, Bowman, Andrew, Brainard, Jason C., Chaibi, Khalil, Chandler, Mark, Ciarallo, Christopher L., Coulson, Colin, Davis, Christopher P., Davis, Jeffrey, DeMaria, Samuel, Jr, Douin, David J., Fingerman, Mitchell, Fung, Philip, Garcia, Paul, Gaudry, Stephane, Gibbons, Erin, Gilliland, Samuel, Goldberg, Andrew, Gruffi, Thomas R., Guffey, Ryan, Gulvezan, Thomas, Hoagland, Monica, Hsu, Eugene, Ing, Richard, Janik, Daniel J., Juels, Alma N., Kacmar, Rachel, Kearns, Mark, Keech, Brian M., Kim, Michael, Krause, Martin, Krishna, Alison, Lahsaei, Peiman, Laterza, Ryan D., Lawless, Ryan A., Lee, Marshall, Levine, Adam I., Lipper, Justin N., Lippert, Benjamin, Martini, Ross, McCullough, S. Andrew, McGill, Brennan, Miller, Howard J., Miller, Joanna, Moore, Thomas B., Morabito, Joseph, Murray, Aaron, Navaratnam, Manchula, Nelson, Jessica L., O'Connor, Katelyn, Oliva, Anthony M., Olsen, Joanna, Onayemi, Abimbola, Papazian, Jason, Parekh, Raj, Park, Chang H., Phillips, Thomas, Ramadurai, Deepa, Reardon, Brittany, Roberts, Matthew J., Saldana, Robert G., Schiavoni, Nick, Schiffer, Dominique, Schoenfeldt, Joseph, Schwartz, Lawrence I., Scupp, Thomas, Shapiro, David, Sim, Alan J., Slover, Robert H., Slover, Robin, Smith, Natalie K., Somerset, William B., Sparkle, Tanaya, Spindel, Stephen, Stein, Lee D., Stone, Marc E., Toma, Annmarie, Tran, Tim T., Twite, Mark D., Vaidyanathan, Mahesh, Vogel, Scott, von Alvensleben, Johannes, Vullo, John A., Weitzel, Nathaen, Wilkey, Barbara, and Yang, Katie

Published
2021
Full Text
View/download PDF

10. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Author

Coles, Alasdair J., Twyman, Cary L., Arnold, Douglas L., Cohen, Jeffrey A., Christian, Confavreux, Fox, Edward J., Hans Peter Hartung, Eva, Havrdova, Selmaj, Krzysztof W., Weiner, Howard L., Tamara, Miller, Elizabeth, Fisher, Rupert, Sandbrink, Lake, Stephen L., Margolin, David H., Pedro, Oyuela, Panzara, Michael A., Compston, D Alastair S., Gupta, the CARE MS II investigators: Ajay S., Edward, Fox, Glyman, Steven A., Thoits, Timothy K., Sullivan, Herman C., Cascione, Mark C., Rammohan, Kottil W., Gazda, Suzanne K., Wynn, Daniel R., Wray, Sibyl E., Stanton, Elias, Ford, Corey C., Andrew, Goodman, Hughes, Bruce L., Omar Azhar Khan, Vaishnav, Anand G., Stephen, Kirzinger, Lynch, Sharon G., Mattson, David H., Braley, Tiffany J., Mikol, Daniel D., Stephen, Krieger, Tamara Ann Miller, Riskind, Peter N., Roberto, Bomprezzi, Wingerchuk, Dean M., Brian, Steingo, Jeffrey Alan Cohen, Crayton, Heidi J., Cooper, Joanna A., Weiner, Leslie P., Harold Moses, J. r., Agius, Mark A., Ann Doan Do Bass, Lallana, Enrico C., Mitchell, Galen W., Krolczyk, Stanley J., Alireza, Minagar, Burk, Jubelt, Evans, Bradley K., Hunter, Samuel F., Rizvi, Syed A., Sheppard, Christopher A., David Honeycutt, W. M., Joseph, Herbert, Lathi, Ellen S., Gabriel, Pardo, Lily Jung Ilenson, Rothstein, Ted L., Thrower, Ben W., Mary Ann Picone, Mariko, Kita, Grazioli, Erica M., Silliman, Scott L., Thomas, Giancarlo, Gottesman, Malcolm H., Abou Zeid, Nuhad E., Rowe, Vernon D., Boutwell, Christine M., Schaeffer, John D., Riley, Claire S., Edwards, Keith R., Wendt, Jeanette K., G. Kim Bigley J. r., Shubin, Richard A., Silva Markovic Plese, Jones, Davis E., Gary, Clauser, Freedman, Mark S., Francois, Grand’Maison, Jacques, Francois H., Traboulsee, Anthony L., Brunet, Donald G., Marcelo, Kremenchutzky, Charles, Ayotte, Lava, Neil S., Waldman, Stephen R., Janus, Todd J., Stephen Gerard Vincent, Mark, Gudesblatt, Michael, Rossen, Stein, Lee S., Bennett Irving Machanic, Timothy, Vollmer, Gitt, Jeffrey S., Jeffrey, Dunn, Donald, Negroski, Fletcher, Mark H., Adil, Javed, Frohman, Elliot M., Richard, Macdonell, John Owen King, Paine, Mark A., Karyn, Boundy, Simon, Broadley, Steve, Vucic, Stephen, Reddel, Dreyer, Michael D., Raymond, Schwartz, Pamela Ann McCombe, Suzanne, Hodgkinson, Charles, Tilbery, Ferreira, Maria Lucia B., Dagoberto, Callegaro, Marcio Mena Barreto Martins, Jesus Arturo Violante Villanueva, Noemi Santos Caballero, Claudia Venzor Mendoza, Norma Haydee Deri, Alasdair, Coles, Neil James Scolding, Gavin, Giovannoni, Basil, Sharrack, Rog, David J., Giancarlo, Comi, Angelo, Ghezzi, Mancardi, Giovanni L., Durelli, Luca, Antonio, Bertolotto, Ruggero, Capra, Carlo, Pozzilli, Maria Giovanna Marrosu, Hupperts, Raymond M. M., Erik van Munster, Xavier, Montalbán, Rafael Arroyo González, Guillermo Izquierdo Ayuso, Óscar Fernández Fernández, Patrick, Vermersch, Jerome de Seze, Thibault, Moreau, Pierre, Clavelou, Catherine, Lubetzki, Michel, Clanet, Marc, Debouverie, Gilles, Edan, Judith, Haas, Martin, Stangel, Tjalf, Ziemssen, Bernhard, Hemmer, Karl, Baum, Klaus Zettl, U., Herrlinger, U., Wolfgang, Köhler, Gunter, Ochs, Patrick, Oschmann, Klaus Tiel Wilck, Hayrettin, Tumani, Urban, Peter P., Jan, Lycke, Anders, Svenningsson, Ivana, Kovarova, Marta, Vachova, Ivan, Rektor, Radomir, Talab, Krzysztof, Selmaj, Zbigniew, Stelmasiak, Wojciech, Kozubski, Dubois, Benedicte D. P., Dominique, Dive, Christian, Sindic, Karl, Vass, Per Soelberg Sørensen, Thor, Petersen, Mads, Ravnborg, Anat, Achiron, Adi Vaknin Dembinsky, Arnon, Karni, Gusev, Evgeny I., Stolyarov, Igor D., Zavalishin, Igor A., Skoromets, Alexander A., Boyko, Alexei N., Belova, Anna N., Malkova, Nadezhda A., Barantsevich, Evgeniy R., Yakupov, Eduard Z., Perfiliev, Semen V., Poverennova, Irina E., Voloshyna, Natalia P., Nehrych, Tetyana I., Kobys, Tetyana O., Mario, Habek, Vesna, Brinar, Zlatko, Trkanjec, Anton, Vladić, Spomenka Kidemet Piskać, Licia, Antonelli, Jelena, Drulović, Čongor, Nadj, Evica, Dinčić, Gordana, Tončev, UCL - SSS/IONS/CEMO - Pôle Cellulaire et moléculaire, Klinische Neurowetenschappen, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, MUMC+: MA Med Staf Spec Neurologie (9), RS: MHeNs School for Mental Health and Neuroscience, Radiology and nuclear medicine, and NCA - Multiple Sclerosis and Other Neuroinflammatory Diseases

Subjects
Male, Adult, medicine.medical_specialty, Adolescent, CD52, multiple sclerosis, Administration, Cutaneous, Antibodies, Monoclonal, Humanized, law.invention, Young Adult, Multiple Sclerosis, Relapsing-Remitting, Adjuvants, Immunologic, Randomized controlled trial, Recurrence, law, Internal medicine, Humans, Medicine, Glatiramer acetate, Infusions, Intravenous, Adverse effect, Alemtuzumab, disease, business.industry, Multiple sclerosis, Interferon beta-1a, Glatiramer Acetate, General Medicine, Middle Aged, medicine.disease, Treatment Outcome, Immunology, Female, Ocrelizumab, Peptides, business, Immunosuppressive Agents, medicine.drug
Abstract

The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We aimed to assess efficacy and safety of alemtuzumab compared with interferon beta 1a in patients who have relapsed despite first-line treatment.In our 2 year, rater-masked, randomised controlled phase 3 trial, we enrolled adults aged 18-55 years with relapsing-remitting multiple sclerosis and at least one relapse on interferon beta or glatiramer. Eligible participants were randomly allocated in a 1:2:2 ratio by an interactive voice response system, stratified by site, to receive subcutaneous interferon beta 1a 44 μg, intravenous alemtuzumab 12 mg per day, or intravenous alemtuzumab 24 mg per day. Interferon beta 1a was given three-times per week and alemtuzumab was given once per day for 5 days at baseline and for 3 days at 12 months. The 24 mg per day group was discontinued to aid recruitment, but data are included for safety assessments. Coprimary endpoints were relapse rate and time to 6 month sustained accumulation of disability, comparing alemtuzumab 12 mg and interferon beta 1a in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT00548405.202 (87%) of 231 patients randomly allocated interferon beta 1a and 426 (98%) of 436 patients randomly allocated alemtuzumab 12 mg were included in the primary analyses. 104 (51%) patients in the interferon beta 1a group relapsed (201 events) compared with 147 (35%) patients in the alemtuzumab group (236 events; rate ratio 0·51 [95% CI 0·39-0·65]; p0·0001), corresponding to a 49·4% improvement with alemtuzumab. 94 (47%) patients in the interferon beta 1a group were relapse-free at 2 years compared with 278 (65%) patients in the alemtuzumab group (p0·0001). 40 (20%) patients in the interferon beta 1a group had sustained accumulation of disability compared with 54 (13%) in the alemtuzumab group (hazard ratio 0·58 [95% CI 0·38-0·87]; p=0·008), corresponding to a 42% improvement in the alemtuzumab group. For 435 patients allocated alemtuzumab 12 mg, 393 (90%) had infusion-associated reactions, 334 (77%) had infections (compared with 134 [66%] of 202 patients in the interferon beta 1a group) that were mostly mild-moderate with none fatal, 69 (16%) had thyroid disorders, and three (1%) had immune thrombocytopenia.For patients with first-line treatment-refractory relapsing-remitting multiple sclerosis, alemtuzumab could be used to reduce relapse rates and sustained accumulation of disability. Suitable risk management strategies allow for early identification of alemtuzumab's main adverse effect of secondary autoimmunity.Genzyme (Sanofi) and Bayer Schering Pharma.

Published
2012

11. Issuers gain edge on electronic commerce: but ride on electronic superhighway still bumpy

Author

Stein, Lee, Smith, Dorea, Melancon, David, Mahy, Linda, and Krasilovsky, Peter

Subjects
MasterCard International Inc. -- Joint ventures -- 00227560, Visa Inc. -- Joint ventures -- 00213973, Credit and debit card industry -- Marketing, Internet -- Innovations, Banking, finance and accounting industries, Business
Abstract

Issuers stand to gain significantly with increased credit card usage over electronic networks as a result of a recent joint effort by MasterCard and Visa to create a security standard [...]

Published
1995

12. Secrets of the Direct Response Ad Copywriters

Author

Stein, Lee Marc

Subjects
Print advertising -- Methods, Direct-mail advertising -- Methods, Direct-mail advertising -- Usage, Advertising, marketing and public relations
Abstract

For many small to midsized businesses, direct mail isn't always the best way to generate response from prospects. If you don't know the 'WHEN' - when prospects need a particular [...]

Published
2005

13. Millimeter wave sensor requirements for maritime small craft identification

Author

Krapels, Keith, primary, Driggers, Ronald G., additional, Garcia, Jose, additional, Boettcher, Evelyn, additional, Prather, Dennis, additional, Schuetz, Chrisopher, additional, Samluk, Jesse, additional, Stein, Lee, additional, Kiser, William, additional, Visnansky, Andrew, additional, Grata, Jeremy, additional, Wikner, David, additional, and Harris, Russ, additional

Published
2009
Full Text
View/download PDF

14. Talk to me: improving the marketing fulfillment interface

Author

Stein, Lee Marc

Subjects
Direct marketing -- Management, Murphy's law -- Usage, Marketing management -- Methods, Shipment of goods -- Management, Advertising, marketing and public relations, Business
Abstract

Most marketing fulfillment problems can be resolved by better communication between marketing and the fulfillment departments. Steps that can improve fulfillment include: reducing the amount of data on the order form that is unnecessary for the customer, having accurate daily flash counts of order receipts, establishing a company-wide policy on credit approvals for customers who are to be billed later, and having a computer processing system that is compatible with the product billing cycle and flexible enough to handle discount offers. The fulfillment department should read and understand all aspects of a company's marketing plan.

Published
1988

19. Hyperspectral imaging opens life-science vistas.

Author

Lerner, Jeremy and Stein, Lee

Subjects
*SPECTRAL line formation, *SPECTRUM analysis, *LIFE sciences
Abstract

Focuses on the use of hyperspectral imaging spectroscopy (HIS) in life-science research. Background about hyperspectral and multispectral imaging; Why HIS researchers should acquire both spectral and spatial information; Information offered by an imaging spectrometer.

Published
1998

20. Correspondence.

Author

Fosdick, Raymond B., Thomas, Norman, Quinn, John N., Stein, Lee, Byington, Steven T., Harding, T. Swann, and Pickett, George T.

Subjects
LETTERS to the editor, OPIUM trade, CATHOLICS, PUBLIC schools, CULTURE
Abstract

Presents several letters to the editor on articles and topics published in the previous issues. Discussion on an article by Ellen La Motte on the stand of the U.S. against selling of opium; "May Catholics Teach School?," which focused on racial and religious discrimination in public schools; Reader's comments on promotion of individual culture and international amity.

Published
1925

21. Kaposi's Sarcoma Presenting as Linitis Plastica.

Author

Hadjiyane, Carylann, Yungho Lee, Stein, Lee, Jayagopal, Sharada, Shih, Henry, and Pellecchia, Crescens

Subjects
KAPOSI'S sarcoma, CANCER, ABDOMINAL diseases, GASTROINTESTINAL diseases, DIAGNOSIS
Abstract

A 31-yr-old woman presenting with abdominal complaints and fever was found to have linitis plastica on upper gastrointestinal series. Endoscopic studies confirmed these findings; however, pathology revealed the diagnosis to be Kaposi's sarcoma. We believe this to be the first case report of linitis plastica presenting as Kaposi's sarcoma. [ABSTRACT FROM AUTHOR]

Published
1991

22. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Author

Montalban, Xavier, Hauser, Stephen L., Kappos, Ludwig, Arnold, Douglas L., Bar-Or, Amit, Comi, Giancarlo, Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W., Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S., Oratorio, Clinical Investigators, Reingold, Stephen C., Sandberg-Wollheim, Magnhild, Barkhof, Frederik, Dörner, Thomas, Evans, Scott, Mcfarland, Henry F., Steiner, Israel, Yaldizli, Özgür, D Souza, Marcus, Andelova, Michaela, Rust, Heiko, Sedal, Leslie, Taylor, Bruce, Assar, Hamid, Auff, Eduard, Berger, Thomas, Guger, Michael, Pilz, Georg, Wipfler, Peter, Bartholomé, Emmanuel, Decoo, Danny, Becker, Jefferson, Da Silva Filho, Irenio, Diniz, Denise, Gomes Neto, Antônio, Leon, Soniza, Haralanov, Lyubomir, Milanov, Ivan, Bar-Or, Amir, Freedman, Mark, Grand Maison, François, Marriott, James, O Connor, Paul, Selchen, Daniel, Yeung, Michael, Benesova, Yvonne, Krasulova, Eva, Vachova, Marta, Airas, Laura, Elovaara, Irina, Färkkilä, Markus, Korpela, Jaana, Sumelahti, Marja-Liisa, Brassat, David, Brochet, Bruno, Camu, William, Castelnovo, Giovanni, Clanet, Michel, Clavelou, Pierre, Debouverie, Marc, Defer, Giles, Gout, Olivier, Heinzlef, Olivier, Laplaud, David, Lebrun-Frenay, Christine, Papeix, Caroline, Pelletier, Jean, Tourbah, Ayman, Vermersch, Patrick, Vukusic, Sandra, Angstwurm, Klemens, Berghoff, Martin, Förch, Christian, Goebels, Norbert, Haas, Judith, Harms, Lutz, Kleiter, Ingo, Koehler, Jürgen, Lensch, Eckard, Limmroth, Volker, Meuth, Sven, Oschmann, Patrick, Platten, Michael, Then Bergh, Florian, Tumani, Hayrettin, Ziemann, Ulf, Ziemssen, Tjalf, Afradou, Theodora, Fakas, Nikolaos, Tsounis, Stefanos, Vlaikidis, Nikolaos, Jakab, Gábor, Komoly, Sámuel, Rózsa, Csilla, Sátori, Mária, Szabó, Gyöngyi, Vécsei, László, Achiron, Anat, Hellmann, Mark, Karni, Arnon, Karussis, Dimitrios, Milo, Ron, Shahien, Radi, Bertolotto, Antonio, Marrosu, Maria Giovanna, Uccelli, Antonio, Malciene, Lina, Rastenyte, Daiva, Sceponaviciute, Sigla, Castro Farfan, Freddy, Duriez Sotelo, Eduardo, Flores-Rivera, Jose, Reyes Morales, Sarug, Hintzen, Rogier, Hupperts, Raymond, Lynch, Christopher, Mossman, Stuart, Gulowsen Celius, Elisabeth, Gavidia Chucan, Jorge, Perez Villegas, Julio, Pretell Alva, Edwin, Bielecki, Dariusz, Brola, Waldemar, Kochanowicz, Jan, Maciejowski, Maciej, Stelmasiak, Zbigniew, Zbrojkiewicz, Janusz, Cunha, Luis, Gonçalves, José, Mendes, Irene, Sá, João, Salgado, Vasco, Silva, Ana, Balasa, Rodica, Manescu, Silviu, Panea, Cristina Aura, Simu, Mihaela Adriana, Yakupov, Eduard, Álvarez Cermeño, José, Álvarez Cermeño, Carlos, Arroyo, Rafael, Escartín Siquier, Antonio, Fernández, Oscar, Izquierdo Ayuso, Guillermo, Martinez Rodríguez, José Enrique, Fernandez Sanchez, Victoria, Olascoaga Urtaza, Francisco Javier, Meca, Virginia, Olascoaga, Javier, Oreja-Guevara, Celia, Perez Sempere, Angel, Prieto González, José María, Ramió Torrentá, Lluis, Rodríguez-Antigüeda, Alfredo, Saiz, Albert, Gobbi, Claudio, Kuhle, Jens, Galusha, Anatoliy, Goloborodko, Alla, Litovchenko, Tetyana, Moroz, Olena, Sergii Moskovko, Nehrych, Tetyana, Pashkovskyy, Valeriy, Shkolnyk, Valerii, Shulga, Olga, Sokolova, Larysa, Voloshyna, Nataliya, Brex, Peter, Constantinescu, Cris, Duddy, Martin, Schmierer, Klaus, Young, Carolyn, Agius, Mark, Ash, Paul, Bandari, Daniel, Belkin, Martin, Bernitsas, Evanthia, Bowen, James, Cahill, Jonathan, Carpenter, Adam, Carter, Jonathan, Cerghet, Mirela, Conway, Jill, Cooper, Joanna, Coyle, Patricia, Cross, Anne, Ford, Corey, Fox, Edward, Freedman, S. Mitchell, Frohman, Elliot, Gitt, Jeffrey, Gottesman, Malcolm, Gudesblatt, Mark, Hendin, Barry, Hutton, George, Klineova, Sylvia, Krupp, Lauren, Lynch, Sharon, Markowitz, Clyde, Mattson, David, Miller, Aaron, Miravalle, Augusto, Muley, Suraj, Nealon, Nancy, Pardo, Gabriel, Picone, Mary Ann, Racke, Michael, Rizvi, Syed, Rossman, Howard, Rowe, Vernon, Schulman, Alan, Shafer, Stuart, William, Sheremata, Stein, Lee, and Waubant, Emmanuelle

23. Conversion perversions (converting trial subscriptions to full-year subscriptions) (column)

Author

Stein, Lee Marc

Subjects
Direct marketing -- Management, Periodicals -- Subscriptions, Periodical publishing -- Marketing, Company marketing practices, Company business management, Business, Publishing industry
Abstract

Conversion perversions You're feeling terrific. Your new direct mail campaign to acquire subscribers to The Amateur Balloonist has brought in unprecedented response--far beyond even your most overblown projections. That superstar [...]

Published
1989

24. His Last Fight.

Author

Stein, Lee Marc

Subjects
HIS Last Fight (Poem), STEIN, Lee Marc
Abstract

The poem "His Last Fight" by Lee Marc Stein is presented. First Line: Final destination today; Last Line: He refuses to go down for the count.

Published
2019

25. Crystallization of random copolymers based on poly(hexamethylene adipamide)

Author

Schreiber, Stein Lee

Abstract

The effects of crystallization temperature and time for a series of polyamide 66 copolymers have been studied. Measurements were made of the growth rate of spherulites, the melting temperature, and the lamellar thickness. The lamellar thickness was found to be approximately constant at 1 ½ to 2 chemical repeat units. The growth rate is enhanced for the nylon 6T copolymers and reduced for the nylon 6I and nylon 6 copolymers. Although the polymers show typical Tc vs. Tm behavior on a Hoffman- Weeks plot, the Gibbs-Thompson plot indicates that there are only small changes in the lamellar thickness with increasing melting point. Based on calculations of the size of the critical nucleus, the Secondary Nucleation Model does not apply for polyamide 66. The crystallization dynamics are dominated by hydrogen bonding.

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results